Schalkwijk CG - Search Results

1

Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.

Wetzels S, Wouters K, Schalkwijk CG, Vanmierlo T, Hendriks JJ. Wetzels S, et al. Among authors: schalkwijk cg. Int J Mol Sci. 2017 Feb 15;18(2):421. doi: 10.3390/ijms18020421. Int J Mol Sci. 2017. PMID: 28212304 Free PMC article. Review.

2

Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification.

Schalkwijk CG, Stehouwer CD, van Hinsbergh VW. Schalkwijk CG, et al. Diabetes Metab Res Rev. 2004 Sep-Oct;20(5):369-82. doi: 10.1002/dmrr.488. Diabetes Metab Res Rev. 2004. PMID: 15343583 Review.

3

Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine.

van Heijst JW, Niessen HW, Hoekman K, Schalkwijk CG. van Heijst JW, et al. Among authors: schalkwijk cg. Ann N Y Acad Sci. 2005 Jun;1043:725-33. doi: 10.1196/annals.1333.084. Ann N Y Acad Sci. 2005. PMID: 16037299

4

Heat-shock protein 27 is a major methylglyoxal-modified protein in endothelial cells.

Schalkwijk CG, van Bezu J, van der Schors RC, Uchida K, Stehouwer CD, van Hinsbergh VW. Schalkwijk CG, et al. FEBS Lett. 2006 Mar 6;580(6):1565-70. doi: 10.1016/j.febslet.2006.01.086. Epub 2006 Feb 3. FEBS Lett. 2006. PMID: 16487519 Free article.

5

Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs.

Lieuw-a-Fa ML, Schalkwijk CG, Engelse M, van Hinsbergh VW. Lieuw-a-Fa ML, et al. Among authors: schalkwijk cg. Thromb Haemost. 2006 Feb;95(2):320-8. doi: 10.1160/TH05-04-0248. Thromb Haemost. 2006. PMID: 16493495

6

Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study.

Gaens KH, van Der Kallen CJ, van Greevenbroek MM, Feskens EJ, Stehouwer CD, Schalkwijk CG. Gaens KH, et al. Among authors: schalkwijk cg. Ann N Y Acad Sci. 2008 Apr;1126:162-5. doi: 10.1196/annals.1433.013. Epub 2007 Dec 13. Ann N Y Acad Sci. 2008. PMID: 18079485

7

Advanced glycation end products and diabetic foot disease.

Huijberts MS, Schaper NC, Schalkwijk CG. Huijberts MS, et al. Among authors: schalkwijk cg. Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S19-24. doi: 10.1002/dmrr.861. Diabetes Metab Res Rev. 2008. PMID: 18442180 Review.

8

Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.

Nienhuis HL, de Leeuw K, Bijzet J, Smit A, Schalkwijk CG, Graaff R, Kallenberg CG, Bijl M. Nienhuis HL, et al. Among authors: schalkwijk cg. Rheumatology (Oxford). 2008 Oct;47(10):1554-8. doi: 10.1093/rheumatology/ken302. Epub 2008 Aug 13. Rheumatology (Oxford). 2008. PMID: 18701539

9

Modulation of insulin action by advanced glycation endproducts: a new player in the field.

Schalkwijk CG, Brouwers O, Stehouwer CD. Schalkwijk CG, et al. Horm Metab Res. 2008 Sep;40(9):614-9. doi: 10.1055/s-0028-1082085. Epub 2008 Sep 15. Horm Metab Res. 2008. PMID: 18792872 Review.

10

The association between the -374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studies.

Engelen L, Ferreira I, Gaens KH, Henry RM, Dekker JM, Nijpels G, Heine RJ, 't Hart LM, van Greevenbroek MM, van der Kallen CJ, Blaak EE, Feskens EJ, Ten Cate H, Stehouwer CD, Schalkwijk CG. Engelen L, et al. Among authors: schalkwijk cg. J Hypertens. 2010 Feb;28(2):285-93. doi: 10.1097/HJH.0b013e3283330931. J Hypertens. 2010. PMID: 20051912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page